HL
Healios K.K.
HLOSF · OTC
$2.70 +50.00% (+$0.90)
Market Cap ¥37.9B
P/E Ratio 204.88x
Div. Yield -
ROE 3.06%
Piotroski F-Score Moderate
4/9Valuation
12 /100
Expensive P/S 639.98x
P/B 4.36x
P/E 204.88x
Growth
45 /100
Stable Book val. growth 3.75%
Rev. growth 4.97%
FCF growth N/A
Profitability
20 /100
Weak Net margin 312.37%
Op. margin 7,091.59%
FCF margin 7,414.54%
Quality
5 /100
Poor ROE 3.06%
ROA 0.81%
Asset turnover 0.00x
Debt
69 /100
Low Current ratio 2.37x
Int. coverage -1.07x
Debt/Equity 0.29x
Stability
36 /100
Moderate Rev. volatility 230.43%
EPS volatility 21.30%
Profitable years 0
Bulios Scoring popisuje kvalitu a minulost firmy, ne budoucí výnos. Vysoké skóre není nákupní signál. Zjistit více
Zeptejte se StockBota na HLOSF
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Tadahisa S. Kagimoto
Employees
75
Headquarters
Tokyo
Nadcházející události
18 LIS
Earnings
Upcoming earnings report